Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,742,739
+$3,971,463 QoQ
Shares Held
620,157
-10.7% QoQ
Ownership
0.250%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. EXEL ranks #13 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,742,739 | 620,157 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $29,771,276 | 694,131 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,420,100 | 557,155 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $31,878,476 | 771,876 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $82,019,036 | 1,860,686 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $26,204,373 | 709,761 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $15,089,626 | 453,142 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,095,978 | 620,269 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,203,747 | 142,579 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $3,955,574 | 166,691 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $4,121,695 | 171,809 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,567,088 | 117,487 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,924,355 | 100,699 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,977,666 | 153,409 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,545,248 | 345,714 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,922,851 | 377,733 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,916,824 | 572,374 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,854,133 | 346,455 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,586,511 | 305,608 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,155,029 | 243,852 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,625,624 | 308,761 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,274,987 | 233,510 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $4,434,303 | 220,942 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,300,635 | 216,795 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,190,203 | 218,627 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,850,510 | 281,679 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||